RU2010129032A - METHOD FOR INCREASING PROLIFERATIVE ACTIVITY OF PERIPHERAL BLOOD LYMPHOCYTES - Google Patents

METHOD FOR INCREASING PROLIFERATIVE ACTIVITY OF PERIPHERAL BLOOD LYMPHOCYTES Download PDF

Info

Publication number
RU2010129032A
RU2010129032A RU2010129032/15A RU2010129032A RU2010129032A RU 2010129032 A RU2010129032 A RU 2010129032A RU 2010129032/15 A RU2010129032/15 A RU 2010129032/15A RU 2010129032 A RU2010129032 A RU 2010129032A RU 2010129032 A RU2010129032 A RU 2010129032A
Authority
RU
Russia
Prior art keywords
nle
peripheral blood
proliferative activity
ala ser
tyr lys
Prior art date
Application number
RU2010129032/15A
Other languages
Russian (ru)
Other versions
RU2465001C2 (en
Inventor
Александр Владимирович Зурочка (RU)
Александр Владимирович Зурочка
Юрий Геннадьевич Суховей (RU)
Юрий Геннадьевич Суховей
Владимир Александрович Зурочка (RU)
Владимир Александрович Зурочка
Мария Александровна Добрынина (RU)
Мария Александровна Добрынина
Сергей Анатольевич Петров (RU)
Сергей Анатольевич Петров
Ирина Генриховна Унгер (RU)
Ирина Генриховна Унгер
Елена Геннадьевна Костоломова (RU)
Елена Геннадьевна Костоломова
Original Assignee
Учреждение Российской академии наук Тюменский научный центр Сибирского отделения РАН (ТюмНЦ СО РАН) (RU)
Учреждение Российской академии наук Тюменский научный центр Сибирского отделения РАН (ТюмНЦ СО РАН)
Александр Владимирович Зурочка (RU)
Александр Владимирович Зурочка
Юрий Геннадьевич Суховей (RU)
Юрий Геннадьевич Суховей
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Учреждение Российской академии наук Тюменский научный центр Сибирского отделения РАН (ТюмНЦ СО РАН) (RU), Учреждение Российской академии наук Тюменский научный центр Сибирского отделения РАН (ТюмНЦ СО РАН), Александр Владимирович Зурочка (RU), Александр Владимирович Зурочка, Юрий Геннадьевич Суховей (RU), Юрий Геннадьевич Суховей filed Critical Учреждение Российской академии наук Тюменский научный центр Сибирского отделения РАН (ТюмНЦ СО РАН) (RU)
Priority to RU2010129032/15A priority Critical patent/RU2465001C2/en
Publication of RU2010129032A publication Critical patent/RU2010129032A/en
Application granted granted Critical
Publication of RU2465001C2 publication Critical patent/RU2465001C2/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Способ повышения пролиферативной активности лимфоитов периферической крови, заключающийся в применении синтетического средства, в лекарственной основе, согласно изобретения, в качестве синтетического средства используют синтетические пептиды, имеющие структуру от LYS GLY PRO LEY THR NLE NLE ALA SER HIS TYR LYS GLN HIS CYS PRO и до THR NLE NLE ALA SER HIS TYR LYS GLN HIS CYS PRO, м.м. от 1794 до 1397 дальтон, в концентрациях от 10-4 до 10-5 мг/мл лекарственной основы, в качестве которой используют физиологический раствор, применяют один раз в сутки. A method of increasing the proliferative activity of peripheral blood lymphoids, which consists in using a synthetic agent in a drug basis, according to the invention, using synthetic peptides having a structure from LYS GLY PRO LEY THR NLE NLE ALA SER HIS TYR LYS GLN HIS CYS PRO and up to a synthetic agent THR NLE NLE ALA SER HIS TYR LYS GLN HIS CYS PRO, m. from 1794 to 1397 daltons, in concentrations from 10-4 to 10-5 mg / ml of the drug base, which is used as a physiological solution, is used once a day.

Claims (1)

Способ повышения пролиферативной активности лимфоитов периферической крови, заключающийся в применении синтетического средства, в лекарственной основе, согласно изобретения, в качестве синтетического средства используют синтетические пептиды, имеющие структуру от LYS GLY PRO LEY THR NLE NLE ALA SER HIS TYR LYS GLN HIS CYS PRO и до THR NLE NLE ALA SER HIS TYR LYS GLN HIS CYS PRO, м.м. от 1794 до 1397 дальтон, в концентрациях от 10-4 до 10-5 мг/мл лекарственной основы, в качестве которой используют физиологический раствор, применяют один раз в сутки. A method for increasing the proliferative activity of peripheral blood lymphoids, which consists in using a synthetic agent in a drug basis, according to the invention, using synthetic peptides having a structure from LYS GLY PRO LEY THR NLE NLE ALA SER HIS TYR LYS GLN HIS CYS PRO and up to a synthetic agent THR NLE NLE ALA SER HIS TYR LYS GLN HIS CYS PRO, m. from 1794 to 1397 daltons, in concentrations from 10 -4 to 10 -5 mg / ml of the drug base, which is used as a physiological solution, is used once a day.
RU2010129032/15A 2010-07-13 2010-07-13 Method for increasing proliferative activity of peripheral blood lymphocytes RU2465001C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2010129032/15A RU2465001C2 (en) 2010-07-13 2010-07-13 Method for increasing proliferative activity of peripheral blood lymphocytes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2010129032/15A RU2465001C2 (en) 2010-07-13 2010-07-13 Method for increasing proliferative activity of peripheral blood lymphocytes

Publications (2)

Publication Number Publication Date
RU2010129032A true RU2010129032A (en) 2012-01-20
RU2465001C2 RU2465001C2 (en) 2012-10-27

Family

ID=45785281

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2010129032/15A RU2465001C2 (en) 2010-07-13 2010-07-13 Method for increasing proliferative activity of peripheral blood lymphocytes

Country Status (1)

Country Link
RU (1) RU2465001C2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2080120C1 (en) * 1994-07-19 1997-05-27 Совместное русско-американское акционерное общество закрытого типа "Неофарм" Agent showing immunomodulating activity
EP1855724A2 (en) * 2005-02-01 2007-11-21 Research Development Foundation Blys fusion proteins for targeting blys receptor and methods for treatment of b-cell proliferative disorders

Also Published As

Publication number Publication date
RU2465001C2 (en) 2012-10-27

Similar Documents

Publication Publication Date Title
NZ592509A (en) HLA-A*1101-restricted WTI peptide and pharmaceutical composition comprising the same
BR112016029848A2 (en) mic-1 fusion proteins and uses thereof
FI3430027T3 (en) Peptide for use in immunotherapy against non-small cell lung cancer and small cell lung cancer
EA201101706A1 (en) Drug medication based on diyndolylmethanum (DIM) with enhanced bioavailability and its use in the treatment of hyperplastic and inflammatory diseases
MX2009007267A (en) An insulinotropic complex using an immunoglobulin fragment.
EA201491605A1 (en) WAYS TO IMPROVE THE DIAPHRAGM FUNCTION
PE20121393A1 (en) PEPTIDE ANALOGUE OF OXYNTHOMODULIN
CY1120618T1 (en) ANALOGUES OF COMPETITIVE MU OPIODIC RECEPTORS OF ENDOMORPHIN
NZ608502A (en) Polypeptides that bind to human complement component c5
CO6351689A2 (en) PHARMACEUTICAL FORMULATIONS CONTAINING LEGANDS OF DOPAMINE RECEIVERS
RU2015102772A (en) Benzodiazelipas for small cell lung cancer
EA200700976A1 (en) COMPOUNDS IN THE FORM OF MOLECULE-CONJUGATES, HAVING ENHANCED ACTIVITY WITH RESPECT TO THE INCLUSION OF CELL
WO2011156453A3 (en) Therapeutic peptides
RU2012157683A (en) INSULIN DERIVATIVES CONTAINING ADDITIONAL DISULPHIDE LINKS
EA201490901A1 (en) LINKERS BASED ON TYROSINE FOR FREE CONNECTION OF PEPTIDE
PE20142275A1 (en) IL-17 ANTIBODY FORMULATION
RU2013146690A (en) CYCLIC PEPTIDES WITH ANTINEOPLASTIC AND ANTI-ANGIONENOUS ACTIVITY
CY1115629T1 (en) USE OF TROP Peptide Compounds and Pharmaceutical Compositions in Anemia Therapy
RU2015116264A (en) COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE IN PATIENTS WITH DIABETES
MX349364B (en) Novel alpha 1-antitrypsin variant, preparation method thereof, and use thereof.
EA201390722A1 (en) CANCER TREATMENT BY IMPROVED DOSES OF SOLUBLE PROTEINS OF FGFR1 MERGER
EA201401148A1 (en) BIOLOGICAL ACTIVE PEPTIDE COMPLEXES
UA109544C2 (en) PHARMACEUTICAL COMPOSITION CONTAINING PARACETAMOL AND METHOD OF MANUFACTURING
RU2010129032A (en) METHOD FOR INCREASING PROLIFERATIVE ACTIVITY OF PERIPHERAL BLOOD LYMPHOCYTES
EP4218786A3 (en) Opiorphin for use as analgesic agent

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20130714